Hope for people living with multi-drug resistant HIV...

AVERT | 2017-06-12 15:48 UTC

Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.

By AVERT on 2017-06-12 15:48 UTC
  • Need an account?